ABSTRACT Resistant starch has been reported to act as a protective agent against pathogenic organisms in the gut and to encourage the proliferation of beneficial organisms. This study examined the efficacy of acetylated high amylose maize starch (SA) and butyralated high-amylose maize starch (SB) in reducing the severity of necrotic enteritis (NE) in broilers under experimental challenge. A total of 720 one-day-old male Ross 308 chicks were assigned to 48 floor pens with a 2 × 4 factorial arrangement of treatments. Factors were a) challenge: no or yes; and b) feed additive: control, antibiotics (AB), SA, or SB. Birds were challenged with Eimeria and C. perfringens according to a previously reported protocol. On d 24 and 35, challenged birds had lower (P < 0.001) livability (LV), weight gain (WG), and feed intake (FI) compared to unchallenged birds. Challenged birds fed SA and SB had higher FI and WG at d 24 and 35 (P < 0.05) compared to birds fed the control diet, while being significantly lower than those fed AB. Unchallenged birds fed SA or SB had higher FI at d 24 and 35 compared to those fed the control diet (P < 0.05). Birds fed SB had increased (P < 0.001) jejunal villus height/crypt depth (VH:CD) ratios at d 15, increased ileal (P < 0.001) and caecal (P < 0.001) butyrate levels at d 15 and 24, and decreased (P < 0.01) caecal pH at d 15. Birds fed SA had increased (P < 0.001) ileal acetate content at d 24 and decreased (P < 0.01) caecal pH at d 15. These results demonstrated that dietary acylated starch improved WG in birds challenged with necrotic enteritis. Depending on the acid used, starch acylation also offers a degree of specificity in short chain fatty acid (SCFA) delivery to the lower intestinal tract which improves gut health.
INTRODUCTION
Necrotic enteritis (NE) is an economically important bacterial disease in poultry (Timbermont et al., 2011) . The causative agent of NE is Clostridium perfringens, which is a Gram-positive, anaerobic bacterium that can be found in poultry litter, excreta, soil, dust, and in the intestinal contents of healthy birds (Williams, 2005) . Necrotic enteritis is characterized by necrosis and inflammation of the small intestine with a significant decline in bird performance and, in clinical cases, a massive increase in flock mortality (Van der Sluis, 2000) . Traditionally, NE has been controlled by antibacterial feed additives such as virginiamcin, lincomycin, bacitracin, tylosin, penicillin, and avoparcin (Williams, 2005) . Dietary antimicrobials can not only control NE outbreaks, but can also improve poultry growth and feed conversion efficiency (Kim et al., 2011) . However, public concern over the use of in-feed antibiotics and the emergence of antibiotic-resistant microorganisms has Resistant starch is the fraction of ingested starch which is not digested by digestive enzymes in the small intestine and therefore escapes into the large bowel (Asp and Björck, 1992) . Resistant starch can be a protective agent against many pathogenic organisms in the gut through the production of short chain fatty acids (SCFA) (Topping and Clifton, 2001 ). Indeed, SCFA have an important role in maintaining the physiological function of the large bowel (Annison et al., 2003) . Although the concentration of SCFA may be manipulated in the gut by provision of appropriate substrates in the diet, it is not easy to selectively increase certain types of SCFA in a substantial manner. Thus, acylating carbohydrates such as starch, with specific SCFA may offer a degree of specificity in SCFA delivery. Acetylated starches are resistant to small intestine digestion and esterified acids released by bacterial enzymes are available for utilization and absorption by gut microbes and colonocytes (Abell et al., 2011) . The studies on acylated starch have been performed on test animals for human health and nutrition purposes. Thus, the present study was designed to investigate the efficacy of acetylated 2434 Downloaded from https://academic.oup.com/ps/article-abstract/94/10/2434/1507273 by guest on 27 February 2019 high amylose maize starch (SA) and butyralated highamylose maize starch (SB) in ameliorating the severity of necrotic enteritis in broilers under experimental disease challenge.
MATERIAL AND METHODS
The experiment was approved by the Animal Ethics Committee of the University of New England (Approval No: AEC13-064).
Animal Husbandry
A total of 720 one-day-old male Ross 308 chicks were placed in 48 floor pens in the University of New England Animal House Complex, Armidale, NSW, Australia. All the birds were vaccinated against Marek's disease and infectious bronchitis. The birds were randomly assigned to 8 treatments with 6 replicate pens per treatment and 15 birds in each pen. Pens (wire mesh partitioned at 120 × 75 cm) were divided into 2 partitions to prevent control birds from infection of NE in the same environmentally controlled facility. The room temperature was set at 33 to 34
• C initially and gradually decreased by 3
• C per week until 22 to 24 • C was reached by the third week. Fluorescent light was provided for 23 hours between d 0 to 7 (40 lux), then 18 hours from d 7 to 30 (10 lux), and 23 hours from d 30 to 35 (10 lux). Each pen was equipped with a separate tube feeder and nipple drinkers with water and feed provided ad libitum. During the trial period, starter diets were fed during d 0 to 10, grower diets between d 10 to 24, and finisher diets between d 24 to 35. The primary determinants of performance, i.e., cumulative pen weight, feed intake (FI), livability (LV) and feed conversion ratio (FCR) were measured at d 10, 24, and 35.
Dietary Treatment
Four diets were formulated with wheat, soybean meal, meat and bone meal, and canola meal according to Ross 308 nutrient specifications (Table 1) . The diets were thoroughly mixed and pelleted at 65
• C. Treatments were arranged in a 2 × 4 factorial arrangement, i.e., challenge: no or yes; feed additives: control (no additive), control diet supplemented with antibiotics (AB) 0.5 g/kg salinomycin and 0.33 g/kg zinc bacitracin in starter, grower, and finisher diets, control diet supplemented with 50 g/kg SA in starter, grower, and finisher diets, and control diet supplemented with 50 g/kg SB in starter, grower and, finisher diets. The Concept 5 feed formulation program (Creative Formulation Concepts, LLC, Annapolis, MD) was used to formulate diets. Starch additives were added over the top. Custom-formulated broiler premixes as well as salinomycin (Sacox 120) were purchased from BEC Feed Solutions P/L, (Brisbane, QLD, Australia) and zinc bacitracin (Albac 150) was purchased from Ridley AgriProducts (Tamworth, NSW, Australia). The acylated starch products were purchased from the CSIRO Division of Animal, Food and Health Sciences, Adelaide, South Australia. The degree of substitution of acetate in SA and butyrate in SB was 0.20 and 0.23 respectively.
Necrotic Enteritis Challenge
The NE challenge was performed based on previous reports with modifications Rodgers et al., 2015) . The Eimeria acervulina (batch E1-3/11-064), E. brunetti ("Roybru", batch E2-3/11-072) and E. maxima (batch E9-6/11-072) were all vaccine strains obtained from Bioproperties Pty. Ltd.
(Glenorie, NSW, Australia). Clostridium perfringens type A strain EHE-NE18 obtained from CSIRO Livestock Industries (Geelong, Australia) was incubated overnight at 39åC in 100 mL of sterile thioglycollate broth (USP alternative; Oxoid) followed by subsequent overnight incubations of 1 mL of the previous culture in 100 mL of cooked meat medium (Oxoid), and then in 700 mL of thioglycollate broth (USP alternative; Oxoid) containing starch (10 g/L) and pancreatic digest of casein (5 g/L) to obtain the challenge inoculum. On d 9, challenged birds were inoculated with 5,000 sporulated oocysts each of E. maxima and E. acervulina and 2,500 sporulated oocysts of E. brunetti in 1 mL of 1% (w/v) sterile saline. Non-challenged birds received 1 mL of 1% (w/v) sterile saline. On d 14, birds were inoculated twice at an interval of 5 h with 2 mL of C. perfringens (EHE-NE18, CSIRO) suspension (3.8×10 8 CFU/mL).
Sample Collection
On d 15 and 24, three birds and two birds, respectively, were randomly selected from each pen, weighed, and euthanised by cervical dislocation. Digesta samples from the ileum and caeca were collected and stored in 50 mL plastic containers and frozen directly at −20
• C for SCFA analysis. Around 1 g of content was used to measure the pH. Approximately 1 g of cecal digest was collected in a 2mL Eppendorf tube, snap-frozen in liquid nitrogen, and stored at −20
• C for bacteria quantification. Approximately 1 cm of the jejunum from one bird in each pen was collected for morphometric analysis. The tissue was opened and flushed clean with phosphate buffered saline (pH 7.4) and fixed in 10% buffered formalin for 24 hours. Formalin was subsequently replaced by 70% ethanol for long-term storage. On d 15, intestinal tissues (duodenum, jejunum, and ileum) were scored for NE lesions according to Prescott et al. (1978) and Broussard et al. (1986) .
Measurements and Analysis
Ileal and Cecal pH. The ileal and cecal pH values were measured at d 15 and 24. Approximately 1 g of contents was diluted in 9 mL of distilled water. The suspension was mixed with a stirrer and the pH was determined by the EcoScan 5/6 pH meter (Eutech Instrument Pty Ltd., Singapore).
Analysis of Short Chain Fatty Acids. The analytical method described by Jensen et al. (1995) was used for the SCFA analysis.
Analysis of Starch.
The total starch content of the feed samples was determined using the Megazyme total starch assay.
Histology. Fixed samples were dehydrated, cleared and embedded in paraffin wax for subsequent histological analysis. Consecutive longitudinal sections (7 μm) were placed individually onto Superfrost R slides (Thermo Scientific, Rockville, MD) and stained with hematoxylin and eosin. Villus height and crypt depth were measured by the video pro 32 program and the images captured with a color video camera (Sony R SSC-DC93P). The height of 10 villi and the depth of 10 crypts were measured from each replicate. The means was obtained from these values and the villus height/crypt depth ratio (VH:VD) was determined.
Quantification of Cecal Bacteria. Cecal digesta DNA was extracted by using the ISOLATE II Plant DNA Kit (Bioline, Alexandria, NSW, Australia) following the manufacturer's instructions with slight modifications. Briefly, 300 mg glass beads (0.1 mm; Biospec Products, Bartlesville, OK) and around 200 mg frozen digesta were placed into 2 mL Eppendorf tubes followed by the addition of 450 μL lysis buffer. The samples were shaken on a Mixer Mill MM 300 (Retsch GmbH & Co, Haan, Germany) at a frequency of 30/s for 5 minutes, and heated at 95
• C for 5 minutes. The cells were lysed after adding 200 μL and then 100 μL of Extraction Buffer (2M NaCl, 20mM EDTA, 100mM Tris/HCl, 2% CTAB, 2% polyvinylpyrrolidone, pH 8.0) with vortexmixing following each addition. Following centrifugation at 4,600 × g 600 μL sample was incubated at 65
• C following the addition of 10 μL RNase to remove RNA. A total of 450 μL Binding Buffer was used to capture DNA, 400 μL Wash Buffer PAW1 and 700 μL PAW2 to remove impurity, and 50 μL Elution Buffer to dissolve DNA.
The quantitative real-time PCR assay of domain bacteria, Enterobacteriaceae, lactobacilli and Clostridium perfringens was performed following the method of Wise and Siragusa (2006) . The extracted DNA from cecal digesta was diluted 20 times in sterilized water; TaqMan universal PCR master mix (Applied Biosystems, Foster City, CA) was used to quantify C. perfringens and SensiMix TM SYBR R No-ROX Kit was used to quantify total bacteria, Enterobacteriaceae, and lactobacilli. Species-specific 16 rRNA primers/probe were used for the C. perfringens (primers: CG-CATAACGTTGAAAGATGG and CCTTGGTAG-GCCGTTACCC, and TaqMan probe: 5 -FAM-TCATCATTCAACCAAAGGAGCAATCC-TAMRA-3 ), the Enterobacteriaceae (F: CATTGACGT-TACCCGCAGAAGAAGC and R: CTCTAC-GAGACTCAAGCTTGC), the lactobacillus spp. (F: CACCGCTACACATGGAG and R:AGCAGTAGGGAATCTTCCA), and domain bacteria (F: CGGYCCAGACTCCTACGGG and R: TTACCGCGGCTGCTGGCAC). PCR was performed in a Rotorgene 6500 real-time PCR machine and the quantification conducted by the Rotorgene 6000 series software 1.7 (Corbett, Sydney, Australia). A threshold cycle average from the replicate samples was used for data analysis. Serial dilutions of linearized plasmid DNA (pCR R 4-TOPO Vector, Life Technologies, Carlsbad) inserted with respective bacterial amplicons were used to construct a standard curve. The concentrations of the plasmid DNA were measured using NanoDrop ND-8000 (Thermo Fisher Scientific, Waltham) prior to the serial dilutions. The number of target DNA copies was calculated from the mass of DNA taking into account the size of the amplicon insert in the plasmid.
Statistical Analysis. The SAS statistical package (PROC GLM) was used to determine significance and interactions of main effects (SAS, SAS Institute, Cary, North Carolina, 2013). When interactions were observed (P < 0.05), Duncan's multiple range test was used to detect the differences between individual treatment means. The SAS statistical package (PROC NPAR1WAY WILCOXON) was used to determine statistical significance of LV, lesion scores, and quantification of C. perfringens.
RESULTS

Broiler Performance
Performance of the birds was not affected by feed additives prior to necrotic enteritis challenge. Challenge resulted in decreased performance as shown in Tables 2 and 4. From d 0 to 10, i.e., one d after challenge with Eimeria, there were no differences in performance between the challenged and unchallenged birds (Table 2) or between any of the additive treatments. No challenge × feed additive interactions observed during this period (P > 0.05).
From d 0 to 24, the effect of the challenge was clearly visible in controls (Table 3 ). Significant challenge × additive interactions (P < 0.001) were observed for FI, WG, and LV and there was a tendency (P < 0.057) for an FCR interaction. The WG, FI, and LV of the challenged control birds were 77%, 82%, and 80% of unchallenged birds (P < 0.001), respectively. Birds fed SB had poorer FCR than those fed control or AB diets (P < 0.001). Unchallenged birds showed no difference in WG and LV as a result of feed additive inclusion (P > 0.05) while FI of birds fed SA and SB was higher (P < 0.05) than those fed control or AB diets. Under challenge conditions, the birds fed SA and SB had increased WG and FI compared to birds fed the control diet (P < 0.05) but were lower than birds fed the AB diet (P < 0.05). Challenged birds fed AB the diet had higher LV than control, SA or SB fed birds. Weight gain, FI, FCR, and LV of challenged birds fed the AB diet were not different from unchallenged birds fed control or AB diets (P > 0.05).
From d 0 to 35, challenge × feed additive interactions were observed for WG, FI, and LV (P < 0.01) but not FCR (P = 0.48). In unchallenged birds, SA and SB fed birds had higher FI but not different WG than control or AB fed birds, while in the challenged group, AB, SA, and SB fed birds all had higher FI and WG when compared to control fed birds. There was no effect of challenge on FCR (P > 0.05) but FCR was higher in SA and SB fed birds as compared to AB or controls across the challenge (P > 0.001). Birds fed AB diets had significantly higher LV than those fed the control, SA, or SB diets under challenge but feed additives treatments were all the same without challenge (P < 0.001).
Necrotic Enteritis Lesion Scores
Necrotic enteritis lesion scores are shown in Table 5 . On d 15, The NE challenge was effective in inducing gross NE lesions in the intestinal tissues, whereas birds in the unchallenged groups had no detectable lesions, as expected. All challenged birds except those given antibiotics showed a higher intestinal NE lesion score compared to unchallenged birds (P < 0.001). Intestinal NE lesion scores of challenged birds fed antibiotics were significantly lower than those of the control, SA and SB groups (P < 0.001).
Ileal and Cecal pH
Ileal and cecal digesta pH were lower (P < 0.01) in challenged than unchallenged birds on d 15 (Table 5) . Birds fed SA and SB had decreased ileal digesta pH compared to AB (P < 0.05) at d 15. Cecal digesta pH was lower in AB, SA, and SB fed birds relative to control on d 15 (P < 0.01). On d 24, challenge × additive interactions were observed for ileal (P < 0.05) and cecal (P < 0.05) digesta pH. The highest ileal digesta pH was recorded for challenged birds fed AB. Unchallenged birds fed SA had lower cecal pH than those fed AB.
Ileal and Cecal SCFAs
Ileal digesta SCFA were measured at d 15 and 24 in birds fed the additive diets (Table 6) . On d 15, ileal formate (P < 0.05), propionate (P < 0.001) and butyrate (P < 0.001) concentrations were all increased by the challenge. Feed additives had a significant effect on ileal SCFA contents. Birds fed SB had increased ileal butyrate when compared to those fed SA, AB, or control (P < 0.001), and ileal lactate compared to AB (P < 0.01). Dietary SA and control birds had more ileal acetate compared to SB and AB fed birds. There was a significant challenge × additive interaction for butyrate (P < 0.001) concentration. Unchallenged birds fed SB had the highest ileal butyrate content compared to other treatments (P < 0.05). Challenged birds fed AB showed decreased ileum butyrate (P < 0.05) compared to challenged birds fed control, SA, and SB diets. No differences were detected in ileal butyrate between challenged and unchallenged birds fed SB (P > 0.05).
On d 24, challenged birds had higher ileal levels of formate (P < 0.02) and butyrate (P < 0.01) than unchallenged birds. Birds fed SA and SB had increased ileal acetate and butyrate levels (P < 0.001), respectively. Challenge × additive interactions were observed for butyrate (P < 0.01) and lactate (P < 0.01) concentrations. Unchallenged and challenged birds fed SB had the highest ileal butyrate content compared to others treatments (P < 0.05). Lactate concentration of birds fed the control and SA was higher than those fed AB under challenge conditions (P < 0.05).
Cecal digesta SCFA are shown in Table 7 . On d 15, lactate in cecal contents of challenged birds was higher than in unchallenged birds (P < 0.039). There were no differences among additives for acetate, propionate, and lactate (P > 0.05). There were significant challenge × additive interactions for cecal acetate (P < 0.02) and butyrate (P < 0.003) concentrations. No differences were detected in cecal acetate of challenged birds, while unchallenged birds fed antibiotics had lower acetate than birds fed SA. Unchallenged birds fed SB had the highest cecal butyrate content out of all other treatments (P < 0.05).
On d 24, unchallenged birds had higher (P < 0.01) cecal acetate and butyrate than challenged birds. Birds fed SB had higher cecal butyrate content compared to those fed control, AB, or SA diets (P < 0.001). Control fed birds had higher cecal propionate compared to birds fed SA or SB (P < 0.05).
Gut Morphology
The morphology of jejunal samples was studied after NE challenge and the data are presented in Table 8 . At d 15, challenged birds had higher muscle thickness (P < 0.05), crypt depth (P < 0.001), and lower VH:CD (P < 0.001) than unchallenged birds. Antibiotics decreased crypt depth (P < 0.01) in comparison to SA and control. Birds fed AB and SB had increased VH:CD ratios relative to the control group (P < 0.02).
No challenge × additive interactions were observed (P > 0.05). On d 24, there were no differences in muscle thickness, villus height, or crypt depth between challenged and unchallenged birds. However, birds fed AB had higher (P < 0.05) VH:CD ratio when compared to birds fed control diet. There were no challenge × additive interactions observed (P > 0.05).
Quantification of Bacteria
After C. perfringens challenge, bacterial groups in cecal content were quantified by quantitative PCR analysis. On d 15 an increase in the numbers of C. perfringens (P < 0.001), lactobacillus (P < 0.001), and enterobacteria (P < 0.019) in the ceca of challenged birds was observed, while there were no differences in analyzed bacteria in response to additives (P > 0.05), as shown in Table 9 . A challenge × additive interaction was observed for C. perfringens quantification (P < 0.001). No significant differences were detected in the count of cecal C. perfringens among unchallenged dietary groups, while C. perfringens counts in challenged birds fed AB were lower (P < 0.05) than challenged birds fed control, SA, and SB. The numbers of C. perfringens in challenged birds fed AB were not different than unchallenged birds fed control, AB, SA, and SB.
On d 24, numbers of domain bacteria (P < 0.001), lactobacillus (P < 0.024), and C. perfringens (P < 0.02) were higher in challenged than unchallenged birds (Table 10 ). The numbers of enterobacteria were significantly higher in birds fed SB than in birds fed control and SA diets and higher in birds fed AB in comparison with birds fed control diets (P < 0.002).
DISCUSSION
Necrotic enteritis is a concern to the poultry industry because of production losses, compromised welfare of birds and increased risk of contamination of poultry products for human consumption (Timbermont et al., 2011) . As a potential remedy to this problem, acylated starches were evaluated for their ability to reduce the severity of NE in broilers under an experimental challenge model. In the present study, NE was successfully induced as shown by the depression of WG, FI, FCR, and LV of birds, and the occurrence of lesion in the gut as expected.
To the best of our knowledge, there are no published data on the effects of acylated resistant starches on broiler performance and gut health. The current study demonstrated that acylated starch products did not have the same magnitude of effect as AB in terms of reducing lesions or preventing mortality. This may be due to differences in the mode of action of acylated starch as compared to AB. Antibiotics are known to be directly bacteriocidal while organic acids are only bacteriostatic. In addition, acylated starch may act by shifting the gut microflora to reduce the damaging effect of clostridia and thus enhance immunity. Acylated starch had positive effects on bird performance and gut health. For instance, dietary SA and SB increased body weight gain by 205 and 226 g, respectively, compared to the challenged birds receiving control diets during the 35 d study. This indicates that SA and SB are effective in improving the body weight gain of birds under NE challenge conditions. The improved body weight gain is probably due to the beneficial effect of acetate and butyrate on gut health. One of the indicators of gut health is the type and composition of the gut microbiota (Choct, 2009) . The current results showed that SA and SB increased acetate and butyrate concentrations in the ileum and cecum respectively. Both butyrate and acetate are known to have a positive effect on energy metabolism and gut health (Topping and Clifton, 2001) . Furthermore, supplementation of SB significantly increased VH:CD ratios, showing a long, matured and functionally active villus, in company with a short crypt with constant renewal of cells. It has been reported that SCFA stimulate gastrointestinal cell proliferation through the increase of plasma glucagon-like peptide-2 and ileal proglucagon, glucose transporter expression and protein expression (Tappenden and McBurney, 1998) .
Although, the challenged birds fed SA and SB had higher WG compared to the birds receiving control diets at d 24 and 35, birds fed either starch product had higher FI at d 24 and 35. The increase in FI of birds fed diets containing 5% of the experimental starch products suggested that these additives were not as digestible as starch in other feed ingredients and birds needed to increase intake to compensate for lower energy compared to other treatments. This is plausible as the experimental products were derived from resistant starch. Resistant starch behaves as fiber in monogastric animals (Annison and Topping, 1994) . The effects of high fiber levels on feed passage and FI in poultry is well documented. For instance, González-Alvarado et al. (2010) reported that adding oat hulls, which are high in lignin and cellulose, increased the passage rate of digesta through the distal part of the gastrointestinal tract in chickens and led to increased feed intake.
Animal and human studies have shown that various types of resistant starch promote indices of large bowel health by increasing bowel SCFA and lowering pH (Cummings et al., 1996) . As expected from this study, the greatest increase in SCFA observed was from birds fed SA and SB containing diets. On d 15, birds fed SB had higher ileal and cecal butyrate levels than those fed other treatment diets. On d 24, the highest ileal acetate level was recorded for birds fed SA and highest ileal butyrate level for birds fed SB. The increase in ileal and cecal acetate and butyrate concentrations in the birds fed SA and SB are likely to be the result of the release of esterified acetate and butyrate by bacterial enzymes, rather than the result of de novo fermentation. This may indicate the ability of acylated starch to deliver specific esterified acids into ileum and cecum in significantly greater amounts. This is consistent with data that have been reported in rats (Annison et al., 2003; Bajka et al., 2006) , where butyralated starch increased cecal butyrate concentration. Interestingly, the ileal and cecal SCFA of unchallenged birds were not affected by dietary treatments on d 15 and 24 with the exception of acetate and butyrate. This may suggest that the high-amylose maize starch is not digestible or fermentable by the bacteria present in the ileum and caeca of birds. This was in contrast to data that have been reported previously in rats (Morita et al., 2005) and pigs (Bird et al., 2007) where high amylose starch increased the overall large bowel SCFA. The current study also demonstrates that birds challenged with Eimeria and C. perfringens showed changed ileal and caecal SCFA levels. This confirmed that the inoculation of Eimeria and C. perfringens strongly affected the gut microflora composition as has been reported recently . In the challenged birds, NE increased the pathogenic and non-pathogenic cecal bacteria, which may lead to an increase in cecal fermentation.
This study also demonstrated that NE challenge caused dramatic changes in gut morphology and micoroflora. After C. perfringens inoculation, challenged birds had significantly lower VH:CD ratio and higher crypt depth and muscle thickness compared with unchallenged birds. This was in agreement with the findings of Collier et al. (2008) where a severely impaired intestinal morphology was observed in Eimeria and Clostridium perfringens co-challenged birds. Also, challenged birds showed higher levels of enterobacteria, lactobacilli, and C. perfringens at d 15 and higher levels of domain bacteria, lactobacilli, and C. perfringens at d 24 compared with unchallenged birds. This may be due to the fact that the challenged birds increased mucus production as a result of inflammation of the gastrointestinal tract. It has been proposed that Eimeria infection induces mucogenesis as a result of a host inflammatory response (Collier et al., 2008) and both commensal and pathogenic bacteria are significantly benefited from mucus synthesized or secreted from host goblet cells (Deplancke and Gaskins, 2001) , which provides a growth advantage for the caecal bacteria.
CONCLUSION
To the best of our knowledge, this is the first study demonstrating the efficacy of acetylated resistant starch products on broiler performance and gut health under a NE disease challenge. The data confirm that AB completely protects birds from NE, whereas acetylated starches were effective in limiting performance decline during NE challenge. The results demonstrate that dietary acetylated resistant starch reduces luminal pH values and offers a degree of specificity in SCFA delivery. Dietary SB was effective in improving gut integrity by increasing the VH:CD ratio.
